Global Coagulation Testing Market : Industry Analysis, Growth, Segmentation and Forecast-2020-2026

The Global Coagulation Testing Market is expected to reach a revenue value of $3566.0 Mn by 2026, at a CAGR of 5.9% in the forecast period.

Global Coagulation Testing Market Introduction and Overview

Global Coagulation Testing Market To know about the Research Methodology :- Request Free Sample Report In recent years, blood coagulation monitoring has become crucial to diagnosing causes of haemorrhages, developing anticoagulant drugs, assessing bleeding risk in extensive surgery procedures and dialysis, and investigating the efficacy of haemostatic therapies. In this regard, advanced technologies such as microfluidics, fluorescent microscopy, electrochemical sensing, photo acoustic detection, and micro/Nano electromechanical systems (MEMS/NEMS) have been employed to develop highly accurate, robust, and cost-effective point of care (POC) devices. With increasing prevalence of haemostatic diseases, the demand for blood coagulation testing has increased. To analyse the treatment efficiency against haemostatic diseases, the blood clotting tests are required. The liver plays an important role in the normal functioning of haemostasis, which helps in preventing bleeding and undue activation of coagulation. Liver cancer is the sixth most common-incident cancer globally and the fourth most common cause of cancer death. According to WHO, the mortality rate due to liver cancer was about 11.4% globally in the year 2020. Moreover, advancements in technology for blood coagulation tests is fuelling the market growth. Furthermore, increasing prevalence of liver diseases, thrombophilia, and haemophilia are also augmenting the market growth. Emphasis on the mechanisms of the blood coagulation measurements with different technologies in order to provide an insight to researchers on advantages of certain techniques in detecting disorders, future trends for clinical monitoring and treatments are the associating key factors for the market to grow. Moreover, the role of Nano materials for both detection and treatment, available commercial devices, artificial intelligence in diagnosis, and monitoring for higher accuracy of measurements are also contributing in boosting the market demand. However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period. The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Coagulation Testing Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges. The report has profiled eighteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.

Global Coagulation Testing Market Segment Analysis

By test type, the Prothrombin time (PT) test segment is expected to grow at a significant pace. The segment is expected to generate a revenue value of $2475.5 Mn by 2026, at a CAGR of 5.5%.These tests are used to monitor safety and effectiveness of anticoagulants, and sensitive to the lack of many coagulation factors. PT test is used to investigate clotting blood from extrinsic and common pathways in which factors I (Fibrinogen), II (Prothrombin), V, VII and X contribute. APTT test is measuring clotting from intrinsic and common pathways. Short measurement durations as compared to conventional coagulation tests and their use in pre-hospital emergency services to provide fast and reliable results for patients are key drivers to the market. By end-use, the hospital segment is expected to register a CAGR of 5.6% during the forecast period holding an expected revenue value of $1290.9 Mn in the Coagulation Testing Market. Surgeries and other operations are performed majorly in hospitals, due to availability of all tools and technologies required. Testing procedures conducted in hospitals or hospital-attached outpatient facilities enable ease of handling any emergency situations that may arise.Rapid expansion of hospitals coupled with availability of analysers and consumables based on hospital needs is also expanding the segment. Global Coagulation Testing Market Regional Insights Global Coagulation Testing Market1 North America and Europe are expected to increase the market for coagulation testing in the forecast period. US, UK and Germany are show high adoption rates of instruments such as PT monitors, PT Testing, rising awareness among people and increase in cardiovascular diseases is boosting the market in NA. Europe region is focusing more on the advanced innovations and excellent strategies are anticipated to drive the European Market growth. The number of CVD (Cardiovascular disease) cases has increased in Europe mainly due to rise in the fat consumption. In addition, levels of obesity are high across Europe in both adults and children. These health issues are expected to drive the market growth in the European region. The Asia Pacific market was valued $358.1 Mn in 2016. The market valuation is expected to reach $891.8 Mn by 2025. It is expected to witness significant growth of xx% during the forecast period due to the increasing cardiovascular disorder cases. The allocation of a large amount of healthcare expenditure for hospitals and dispensing medicines to the elderly is expected drive the market demand. The report also helps in understanding Global Coagulation Testing Market dynamics, structure by analysing the market segments and project the Global Coagulation Testing Marketsize. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Coagulation Testing Marketmake the report investor’s guide

Scope of the Report: Inquire before buying

Global Coagulation Testing Market2

Global Coagulation Testing Market, by Region

• North America • Europe • South America • MEA • Asia Pacific

Global Coagulation Testing Market key Players

• Alere INC • F. Hoffmann-La Roche Ltd • Abbott Laboratories • Medtronic • Siemens Healthcare • SYSMEX Corporation • Universal Biosensors, INC • Hemosonics LLC • Helena Laboratories, INC • DiagnosticaStago • S.A.S • Sekisui Medical Co. LTD • Tcoag Ireland LTD • Micro point Biosciences • Thermo Fisher Scientific, INC • NIHON KOHDEN Corporation • Sysmex Corporation • Danaher Corporation

Global Coagulation Testing Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: COAGULATION TESTING Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global COAGULATION TESTING Market Analysis and Forecast 6.1. COAGULATION TESTING Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global COAGULATION TESTING Market Analysis and Forecast, By Product type 7.1. Introduction and Definition 7.2. Key Findings 7.3. COAGULATION TESTING Market Value Share Analysis, By Product type 7.4. COAGULATION TESTING Market Size (US$ Mn) Forecast, By Product type 7.5. COAGULATION TESTING Market Analysis, By Product type 7.6. COAGULATION TESTING Market Attractiveness Analysis, By Product type 8. Global COAGULATION TESTING Market Analysis and Forecast, By Test Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. COAGULATION TESTING Market Value Share Analysis, By Test Type 8.4. COAGULATION TESTING Market Size (US$ Mn) Forecast, By Test Type 8.5. COAGULATION TESTING Market Analysis, By Test Type 8.6. COAGULATION TESTING Market Attractiveness Analysis, By Test Type 9. Global COAGULATION TESTING Market Analysis and Forecast By End users 9.1. Introduction and Definition 9.2. Key Findings 9.3. COAGULATION TESTING Market Value Share Analysis, By End users 9.4. COAGULATION TESTING Market Size (US$ Mn) Forecast, By End users 9.5. COAGULATION TESTING Market Analysis, By End users 9.6. COAGULATION TESTING Market Attractiveness Analysis, By End users 10. Global COAGULATION TESTING Market Analysis, By Region 10.1. COAGULATION TESTING Market Value Share Analysis, By Region 10.2. COAGULATION TESTING Market Size (US$ Mn) Forecast, By Region 10.3. COAGULATION TESTING Market Attractiveness Analysis, By Region 11. North America COAGULATION TESTING Market Analysis 11.1. Key Findings 11.2. North America COAGULATION TESTING Market Overview 11.3. North America COAGULATION TESTING Market Value Share Analysis, By Product type 11.4. North America COAGULATION TESTING Market Forecast, By Product type 11.4.1. Instruments 11.4.2. Consumables 11.5. North America COAGULATION TESTING Market Value Share Analysis, By Test Type 11.6. North America COAGULATION TESTING Market Forecast, By Test Type 11.6.1. PT 11.6.2. APTT 11.6.3. TT 11.6.4. ACT 11.7. North America COAGULATION TESTING Market Value Share Analysis, By End users 11.8. North America COAGULATION TESTING Market Forecast, By End users 11.8.1. Hospitals and Clinics 11.8.2. Laboratories 11.8.3. Home care settings 11.8.4. Others 11.9. North America COAGULATION TESTING Market Value Share Analysis, By Country 11.10. North America COAGULATION TESTING Market Forecast, By Country 11.10.1. U.S. 11.10.2. Canada 11.10.3. Mexico 11.11. North America COAGULATION TESTING Market Analysis, By Country 11.12. U.S. COAGULATION TESTING Market Forecast, By Product type 11.12.1. Instruments 11.12.2. Consumables 11.13. U.S. COAGULATION TESTING Market Forecast, By Test Type 11.13.1. PT 11.13.2. APTT 11.13.3. TT 11.13.4. ACT 11.14. U.S. COAGULATION TESTING Market Forecast, By End users 11.14.1. Hospitals and Clinics 11.14.2. Laboratories 11.14.3. Home care settings 11.14.4. Others 11.15. Canada COAGULATION TESTING Market Forecast, By Product type 11.15.1. Instruments 11.15.2. Consumables 11.16. Canada COAGULATION TESTING Market Forecast, By Test Type 11.16.1. PT 11.16.2. APTT 11.16.3. TT 11.16.4. ACT 11.17. Canada COAGULATION TESTING Market Forecast, By End users 11.17.1. Hospitals and Clinics 11.17.2. Laboratories 11.17.3. Home care settings 11.17.4. Others 11.18. Mexico COAGULATION TESTING Market Forecast, By Product type 11.18.1. Instruments 11.18.2. Consumables 11.19. Mexico COAGULATION TESTING Market Forecast, By Test Type 11.19.1. PT 11.19.2. APTT 11.19.3. TT 11.19.4. ACT 11.20. Mexico COAGULATION TESTING Market Forecast, By End users 11.20.1. Hospitals and Clinics 11.20.2. Laboratories 11.20.3. Home care settings 11.20.4. Others 11.21. North America COAGULATION TESTING Market Attractiveness Analysis 11.21.1. By Product type 11.21.2. By Test Type 11.21.3. By End users 11.22. PEST Analysis 11.23. Key Trends 11.24. Key Developments 12. Europe COAGULATION TESTING Market Analysis 12.1. Key Findings 12.2. Europe COAGULATION TESTING Market Overview 12.3. Europe COAGULATION TESTING Market Value Share Analysis, By Product type 12.4. Europe COAGULATION TESTING Market Forecast, By Product type 12.4.1. Instruments 12.4.2. Consumables 12.5. Europe COAGULATION TESTING Market Value Share Analysis, By Test Type 12.6. Europe COAGULATION TESTING Market Forecast, By Test Type 12.6.1. PT 12.6.2. APTT 12.6.3. TT 12.6.4. ACT 12.7. Europe COAGULATION TESTING Market Value Share Analysis, By End users 12.8. Europe COAGULATION TESTING Market Forecast, By End users 12.8.1. Hospitals and Clinics 12.8.2. Laboratories 12.8.3. Home care settings 12.8.4. Others 12.9. Europe COAGULATION TESTING Market Value Share Analysis, By Country 12.10. Europe COAGULATION TESTING Market Forecast, By Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Sweden 12.10.7. CIS countries 12.10.8. Rest of Europe 12.11. Germany COAGULATION TESTING Market Forecast, By Product type 12.11.1. Instruments 12.11.2. Consumables 12.12. Germany COAGULATION TESTING Market Forecast, By Test Type 12.12.1. PT 12.12.2. APTT 12.12.3. TT 12.12.4. ACT 12.13. Germany COAGULATION TESTING Market Forecast, By End users 12.13.1. Hospitals and Clinics 12.13.2. Laboratories 12.13.3. Home care settings 12.13.4. Others 12.14. U.K. COAGULATION TESTING Market Forecast, By Product type 12.14.1. Instruments 12.14.2. Consumables 12.15. U.K. COAGULATION TESTING Market Forecast, By Test Type 12.15.1. PT 12.15.2. APTT 12.15.3. TT 12.15.4. ACT 12.16. U.K. COAGULATION TESTING Market Forecast, By End users 12.16.1. Hospitals and Clinics 12.16.2. Laboratories 12.16.3. Home care settings 12.16.4. Others 12.17. France COAGULATION TESTING Market Forecast, By Product type 12.17.1. Instruments 12.17.2. Consumables 12.18. France COAGULATION TESTING Market Forecast, By Test Type 12.18.1. PT 12.18.2. APTT 12.18.3. TT 12.18.4. ACT 12.19. France COAGULATION TESTING Market Forecast, By End users 12.19.1. Hospitals and Clinics 12.19.2. Laboratories 12.19.3. Home care settings 12.19.4. Others 12.20. Italy COAGULATION TESTING Market Forecast, By Product type 12.20.1. Instruments 12.20.2. Consumables 12.21. Italy COAGULATION TESTING Market Forecast, By Test Type 12.21.1. PT 12.21.2. APTT 12.21.3. TT 12.21.4. ACT 12.22. Italy COAGULATION TESTING Market Forecast, By End users 12.22.1. Hospitals and Clinics 12.22.2. Laboratories 12.22.3. Home care settings 12.22.4. Others 12.23. Spain COAGULATION TESTING Market Forecast, By Product type 12.23.1. Instruments 12.23.2. Consumables 12.24. Spain COAGULATION TESTING Market Forecast, By Test Type 12.24.1. PT 12.24.2. APTT 12.24.3. TT 12.24.4. ACT 12.25. Spain COAGULATION TESTING Market Forecast, By End users 12.25.1. Hospitals and Clinics 12.25.2. Laboratories 12.25.3. Home care settings 12.25.4. Others 12.26. Sweden COAGULATION TESTING Market Forecast, By Product type 12.26.1. Instruments 12.26.2. Consumables 12.27. Sweden COAGULATION TESTING Market Forecast, By Test Type 12.27.1. PT 12.27.2. APTT 12.27.3. TT 12.27.4. ACT 12.28. Sweden COAGULATION TESTING Market Forecast, By End users 12.28.1. Hospitals and Clinics 12.28.2. Laboratories 12.28.3. Home care settings 12.28.4. Others 12.29. CIS countries COAGULATION TESTING Market Forecast, By Product type 12.29.1. Instruments 12.29.2. Consumables 12.30. CIS countries COAGULATION TESTING Market Forecast, By Test Type 12.30.1. PT 12.30.2. APTT 12.30.3. TT 12.30.4. ACT 12.31. CIS countries COAGULATION TESTING Market Forecast, By End users 12.31.1. Hospitals and Clinics 12.31.2. Laboratories 12.31.3. Home care settings 12.31.4. Others 12.32. Rest of Europe COAGULATION TESTING Market Forecast, By Product type 12.32.1. Instruments 12.32.2. Consumables 12.33. Rest of Europe COAGULATION TESTING Market Forecast, By Test Type 12.33.1. PT 12.33.2. APTT 12.33.3. TT 12.33.4. ACT 12.34. Rest of Europe COAGULATION TESTING Market Forecast, By End users 12.34.1. Hospitals and Clinics 12.34.2. Laboratories 12.34.3. Home care settings 12.34.4. Others 12.35. Europe COAGULATION TESTING Market Attractiveness Analysis 12.35.1. By Test Type 12.35.2. By Product type 12.35.3. By End users 12.36. PEST Analysis 12.37. Key Trends 12.38. Key Developments 13. Asia Pacific COAGULATION TESTING Market Analysis 13.1. Key Findings 13.2. Asia Pacific COAGULATION TESTING Market Overview 13.3. Asia Pacific COAGULATION TESTING Market Value Share Analysis, By Product type 13.4. Asia Pacific COAGULATION TESTING Market Forecast, By Product type 13.4.1. Instruments 13.4.2. Consumables 13.5. Asia Pacific COAGULATION TESTING Market Value Share Analysis, By Test Type 13.6. Asia Pacific COAGULATION TESTING Market Forecast, By Test Type 13.6.1. PT 13.6.2. APTT 13.6.3. TT 13.6.4. ACT 13.7. Asia Pacific COAGULATION TESTING Market Value Share Analysis, By End users 13.8. Asia Pacific COAGULATION TESTING Market Forecast, By End users 13.8.1. Hospitals and Clinics 13.8.2. Laboratories 13.8.3. Home care settings 13.8.4. Others 13.9. Asia Pacific COAGULATION TESTING Market Value Share Analysis, By Country 13.10. Asia Pacific COAGULATION TESTING Market Forecast, By Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. ASEAN 13.10.7. Rest of Asia Pacific 13.11. Asia Pacific COAGULATION TESTING Market Analysis, By Country 13.12. China COAGULATION TESTING Market Forecast, By Product type 13.12.1. Instruments 13.12.2. Consumables 13.13. China COAGULATION TESTING Market Forecast, By Test Type 13.13.1. PT 13.13.2. APTT 13.13.3. TT 13.13.4. ACT 13.14. China COAGULATION TESTING Market Forecast, By End users 13.14.1. Hospitals and Clinics 13.14.2. Laboratories 13.14.3. Home care settings 13.14.4. Others 13.15. India COAGULATION TESTING Market Forecast, By Product type 13.15.1. Instruments 13.15.2. Consumables 13.16. India COAGULATION TESTING Market Forecast, By Test Type 13.16.1. PT 13.16.2. APTT 13.16.3. TT 13.16.4. ACT 13.17. India COAGULATION TESTING Market Forecast, By End users 13.17.1. Hospitals and Clinics 13.17.2. Laboratories 13.17.3. Home care settings 13.17.4. Others 13.18. Japan COAGULATION TESTING Market Forecast, By Product type 13.18.1. Instruments 13.18.2. Consumables 13.19. Japan COAGULATION TESTING Market Forecast, By Test Type 13.19.1. PT 13.19.2. APTT 13.19.3. TT 13.19.4. ACT 13.20. Japan COAGULATION TESTING Market Forecast, By End users 13.20.1. Hospitals and Clinics 13.20.2. Laboratories 13.20.3. Home care settings 13.20.4. Others 13.21. South Korea COAGULATION TESTING Market Forecast, By Product type 13.21.1. Instruments 13.21.2. Consumables 13.22. South Korea COAGULATION TESTING Market Forecast, By Test Type 13.22.1. PT 13.22.2. APTT 13.22.3. TT 13.22.4. ACT 13.23. South Korea COAGULATION TESTING Market Forecast, By End users 13.23.1. Hospitals and Clinics 13.23.2. Laboratories 13.23.3. Home care settings 13.23.4. Others 13.24. Australia COAGULATION TESTING Market Forecast, By Product type 13.24.1. Instruments 13.24.2. Consumables 13.25. Australia COAGULATION TESTING Market Forecast, By Test Type 13.25.1. PT 13.25.2. APTT 13.25.3. TT 13.25.4. ACT 13.26. Australia COAGULATION TESTING Market Forecast, By End users 13.26.1. Hospitals and Clinics 13.26.2. Laboratories 13.26.3. Home care settings 13.26.4. Others 13.27. ASEAN COAGULATION TESTING Market Forecast, By Product type 13.27.1. Instruments 13.27.2. Consumables 13.28. ASEAN COAGULATION TESTING Market Forecast, By Test Type 13.28.1. PT 13.28.2. APTT 13.28.3. TT 13.28.4. ACT 13.29. ASEAN COAGULATION TESTING Market Forecast, By End users 13.29.1. Hospitals and Clinics 13.29.2. Laboratories 13.29.3. Home care settings 13.29.4. Others 13.30. Rest of Asia Pacific COAGULATION TESTING Market Forecast, By Product type 13.30.1. Instruments 13.30.2. Consumables 13.31. Rest of Asia Pacific COAGULATION TESTING Market Forecast, By Test Type 13.31.1. PT 13.31.2. APTT 13.31.3. TT 13.31.4. ACT 13.32. Rest of Asia Pacific COAGULATION TESTING Market Forecast, By End users 13.32.1. Hospitals and Clinics 13.32.2. Laboratories 13.32.3. Home care settings 13.32.4. Others 13.33. Asia Pacific COAGULATION TESTING Market Attractiveness Analysis 13.33.1. By Product type 13.33.2. By Test Type 13.33.3. By End users 13.34. PEST Analysis 13.35. Key Trends 13.36. Key Developments 14. Middle East & Africa COAGULATION TESTING Market Analysis 14.1. Key Findings 14.2. Middle East & Africa COAGULATION TESTING Market Overview 14.3. Middle East & Africa COAGULATION TESTING Market Value Share Analysis, By Product type 14.4. Middle East & Africa COAGULATION TESTING Market Forecast, By Product type 14.4.1. Instruments 14.4.2. Consumables 14.5. Middle East & Africa COAGULATION TESTING Market Value Share Analysis, By Test Type 14.6. Middle East & Africa COAGULATION TESTING Market Forecast, By Test Type 14.6.1. PT 14.6.2. APTT 14.6.3. TT 14.6.4. ACT 14.7. Middle East & Africa COAGULATION TESTING Market Value Share Analysis, By End users 14.8. Middle East & Africa COAGULATION TESTING Market Forecast, By End users 14.8.1. Hospitals and Clinics 14.8.2. Laboratories 14.8.3. Home care settings 14.8.4. Others 14.9. Middle East & Africa COAGULATION TESTING Market Value Share Analysis, By Country 14.10. Middle East & Africa COAGULATION TESTING Market Forecast, By Country 14.10.1. GCC Countries 14.10.2. South Africa 14.10.3. Nigeria 14.10.4. Egypt 14.10.5. Rest of Middle East & Africa 14.11. Middle East & Africa COAGULATION TESTING Market Analysis, By Country 14.12. GCC Countries COAGULATION TESTING Market Forecast, By Product type 14.12.1. Instruments 14.12.2. Consumables 14.13. GCC Countries COAGULATION TESTING Market Forecast, By Test Type 14.13.1. PT 14.13.2. APTT 14.13.3. TT 14.13.4. ACT 14.14. GCC Countries COAGULATION TESTING Market Forecast, By End users 14.14.1. Hospitals and Clinics 14.14.2. Laboratories 14.14.3. Home care settings 14.14.4. Others 14.15. South Africa COAGULATION TESTING Market Forecast, By Product type 14.15.1. Instruments 14.15.2. Consumables 14.16. South Africa COAGULATION TESTING Market Forecast, By Test Type 14.16.1. PT 14.16.2. APTT 14.16.3. TT 14.16.4. ACT 14.17. South Africa COAGULATION TESTING Market Forecast, By End users 14.17.1. Hospitals and Clinics 14.17.2. Laboratories 14.17.3. Home care settings 14.17.4. Others 14.18. Nigeria COAGULATION TESTING Market Forecast, By Product type 14.18.1. Instruments 14.18.2. Consumables 14.19. Nigeria COAGULATION TESTING Market Forecast, By Test Type 14.19.1. PT 14.19.2. APTT 14.19.3. TT 14.19.4. ACT 14.20. Nigeria COAGULATION TESTING Market Forecast, By End users 14.20.1. Hospitals and Clinics 14.20.2. Laboratories 14.20.3. Home care settings 14.20.4. Others 14.21. Egypt COAGULATION TESTING Market Forecast, By Product type 14.21.1. Instruments 14.21.2. Consumables 14.22. Egypt COAGULATION TESTING Market Forecast, By Test Type 14.22.1. PT 14.22.2. APTT 14.22.3. TT 14.22.4. ACT 14.23. Egypt COAGULATION TESTING Market Forecast, By End users 14.23.1. Hospitals and Clinics 14.23.2. Laboratories 14.23.3. Home care settings 14.23.4. Others 14.24. Rest of Middle East & Africa COAGULATION TESTING Market Forecast, By Product type 14.24.1. Instruments 14.24.2. Consumables 14.25. Rest of Middle East & Africa COAGULATION TESTING Market Forecast, By Test Type 14.25.1. PT 14.25.2. APTT 14.25.3. TT 14.25.4. ACT 14.26. Rest of Middle East & Africa COAGULATION TESTING Market Forecast, By End users 14.26.1. Hospitals and Clinics 14.26.2. Laboratories 14.26.3. Home care settings 14.26.4. Others 14.27. Middle East & Africa COAGULATION TESTING Market Attractiveness Analysis 14.27.1. By Product type 14.27.2. By Test Type 14.27.3. By End users 14.28. PEST Analysis 14.29. Key Trends 14.30. Key Developments 15. South America COAGULATION TESTING Market Analysis 15.1. Key Findings 15.2. South America COAGULATION TESTING Market Overview 15.3. South America COAGULATION TESTING Market Value Share Analysis, By Product type 15.4. South America COAGULATION TESTING Market Forecast, By Product type 15.4.1. Instruments 15.4.2. Consumables 15.5. South America COAGULATION TESTING Market Value Share Analysis, By Test Type 15.6. South America COAGULATION TESTING Market Forecast, By Test Type 15.6.1. PT 15.6.2. APTT 15.6.3. TT 15.6.4. ACT 15.7. South America COAGULATION TESTING Market Value Share Analysis, By End users 15.8. South America COAGULATION TESTING Market Forecast, By End users 15.8.1. Hospitals and Clinics 15.8.2. Laboratories 15.8.3. Home care settings 15.8.4. Others 15.9. South America COAGULATION TESTING Market Value Share Analysis, By Country 15.10. South America COAGULATION TESTING Market Forecast, By Country 15.10.1. Brazil 15.10.2. Colombia 15.10.3. Argentina 15.10.4. Rest of South America 15.11. South America COAGULATION TESTING Market Analysis, By Country 15.12. Brazil COAGULATION TESTING Market Forecast, By Product type 15.12.1. Instruments 15.12.2. Consumables 15.13. Brazil COAGULATION TESTING Market Forecast, By Test Type 15.13.1. PT 15.13.2. APTT 15.13.3. TT 15.13.4. ACT 15.14. Brazil COAGULATION TESTING Market Forecast, By End users 15.14.1. Hospitals and Clinics 15.14.2. Laboratories 15.14.3. Home care settings 15.14.4. Others 15.15. Colombia COAGULATION TESTING Market Forecast, By Product type 15.15.1. Instruments 15.15.2. Consumables 15.16. Colombia COAGULATION TESTING Market Forecast, By Test Type 15.16.1. PT 15.16.2. APTT 15.16.3. TT 15.16.4. ACT 15.17. Colombia COAGULATION TESTING Market Forecast, By End users 15.17.1. Hospitals and Clinics 15.17.2. Laboratories 15.17.3. Home care settings 15.17.4. Others 15.18. Argentina COAGULATION TESTING Market Forecast, By Product type 15.18.1. Instruments 15.18.2. Consumables 15.19. Argentina COAGULATION TESTING Market Forecast, By Test Type 15.19.1. PT 15.19.2. APTT 15.19.3. TT 15.19.4. ACT 15.20. Argentina COAGULATION TESTING Market Forecast, By End users 15.20.1. Hospitals and Clinics 15.20.2. Laboratories 15.20.3. Home care settings 15.20.4. Others 15.21. Rest of South America COAGULATION TESTING Market Forecast, By Product type 15.21.1. Instruments 15.21.2. Consumables 15.22. Rest of South America COAGULATION TESTING Market Forecast, By Test Type 15.22.1. PT 15.22.2. APTT 15.22.3. TT 15.22.4. ACT 15.23. Rest of South America COAGULATION TESTING Market Forecast, By End users 15.23.1. Hospitals and Clinics 15.23.2. Laboratories 15.23.3. Home care settings 15.23.4. Others 15.24. South America COAGULATION TESTING Market Attractiveness Analysis 15.24.1. By Product type 15.24.2. By Test Type 15.24.3. By End users 15.25. PEST Analysis 15.26. Key Trends 15.27. Key Developments 16. Company Profiles 16.1. Market Share Analysis, By Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players By price, presence, market share, Test Type, and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A By Regions, Investment and Test Type 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Alere INC 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. F. Hoffmann-La Roche Ltd 16.3.3. Abbott Laboratories 16.3.4. Medtronic 16.3.5. Siemens Healthcare 16.3.6. SYSMEX Corporation 16.3.7. Universal Biosensors, INC 16.3.8. Hemosonics LLC 16.3.9. Helena Laboratories, INC 16.3.10. DiagnosticaStago 16.3.11. S.A.S 16.3.12. Sekisui Medical Co. LTD 16.3.13. Tcoag Ireland LTD 16.3.14. Micro point Biosciences 16.3.15. Thermo Fisher Scientific, INC 16.3.16. NIHON KOHDEN Corporation 16.3.17. Sysmex Corporation 16.3.18. Danaher Corporation 16.3.19. Others

About This Report

Report ID 85316
Category Healthcare
Published Date March 2021
Updated Date Oct 2021
Contact Us